Clinical trials
Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials
Below are recruiting gastric or gastroesophageal junction adenocarcinoma clinical trials, each written for real people, not researchers. We’re tracking 962 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06039917Recruiting
Automatic reminders for stomach precancer follow-up
This study tests whether an automatic reminder system can help more people with stomach precancerous changes get the follow-up checks they need after an upper endoscopy. The goal is to see if the system improves how often patients return for surveillance.
Quanzhou, FujianAges 18 years+ - NCT06671119Recruiting
Weight regain treatment after sleeve gastrectomy with mucosal ablation
This trial tests a procedure to help people who have regained weight after a sleeve gastrectomy. It uses a special technique to treat the stomach lining and may help you lose weight again.
Cary, North CarolinaAges 22–60 - NCT07656649Recruiting
Sip-til-Send: Clear liquids before surgery
This trial tests whether allowing patients to drink clear fluids (like water or juice) up until surgery starts is safe, instead of fasting for hours. It may help you feel more comfortable before your operation.
Bergen, VestlandAges 18 years+ - NCT07646574Enrolling by invitation
Non-surgical treatment after immunotherapy for specific gastric cancer
This trial tests whether patients with advanced gastric cancer (a specific type called dMMR/MSI-H) can be treated without surgery after receiving immunotherapy and chemotherapy. The goal is to see if this approach can control the cancer while avoiding the risks of surgery.
Chengdu, SichuanAges 18 years+ - NCT07651644Recruiting
AI tool to help doctors read gastric cancer imaging
This study tests whether an AI-assisted tool helps radiologists (doctors who read imaging scans) better interpret CT scans of gastric cancer patients. The research compares how accurately doctors read scans with and without AI help.
Shenyang, LiaoningAges Any age - NCT06348420Recruiting
New procedure vs. acid-reducing pills for GERD
This study compares a new procedure called anti-reflux mucosal valvuloplasty (ARMV) to acid-reducing medicines (PPIs) for treating GERD. It may help people who have had reflux for a long time and need daily PPIs.
Jinan, ShandongAges 18–60 - NCT07643298Recruiting
Lidocaine through feeding tube to reduce nausea after weight-loss surgery
This study tests whether delivering lidocaine (a numbing medication) through a feeding tube during weight-loss surgery can reduce nausea and vomiting afterward. You would receive this medication as part of the surgery procedure to see if it helps you feel better in recovery.
Yinchuan, NingxiaAges 18–65 - NCT07638410Recruiting
Getting fit before major cancer surgery
This trial tests whether special preparation exercises and wellness support before chemotherapy and major abdominal or pelvic surgery can help you recover better and stay stronger. You'll work with a team including exercise specialists and mental health counselors before your operation.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07632079RecruitingPhase 2
Fast-Track Radiation and Chemotherapy for Esophageal Cancer
This study tests a shorter course of combined radiation therapy and chemotherapy (using drugs called paclitaxel and carboplatin) to treat esophageal cancer with the goal of curing it. The faster treatment schedule may help patients finish therapy sooner while still being effective.
AmsterdamAges 18 years+ - NCT06610799RecruitingPhase 1
Study of IBI363 for first-line advanced gastric cancer
This trial tests a new drug called IBI363 in patients with advanced gastric or gastroesophageal junction cancer who have not yet received any treatment. The goal is to see if the drug can help shrink tumors or slow the cancer's growth.
Hangzhou, ZhejiangAges 18–75 - NCT07600125Recruiting
Stool test to screen for digestive tract cancers
This study tests whether a stool sample can help detect early signs of cancers in the stomach, colon, and related organs. Researchers will compare stool test results with findings from standard camera procedures to see if this non-invasive approach might catch cancer earlier.
Xi'an, ShaanxiAges 18 years+ - NCT05484128Recruiting
Probiotic for kids taking acid-reducing medicine
This trial studies whether a specific probiotic (Lactobacillus reuteri) is helpful for children who need acid-reducing medicine for reflux or stomach discomfort. It may help improve stomach symptoms while they are on or need treatment with proton pump inhibitors.
BariAges 1–14 - NCT07593820RecruitingPhase 1
CAR-T Cell Study for Advanced HER2-Positive Cancers
This early-stage trial tests a new type of immune cell therapy called CAR-T cells, which are designed to recognize and attack cancer cells that have a protein called HER2. The cells are made from your own immune cells, trained in the laboratory, and given back to you. The study evaluates how safe the treatment is and whether it can shrink tumors.
Barcelona, CataloniaAges 18 years+ - NCT07586384Recruiting
Single-Port vs Standard Laparoscopic Surgery for Stomach Cancer
This trial compares two minimally invasive surgical approaches for early-stage stomach cancer affecting the upper portion. Researchers want to see if a newer single-port technique (using one small incision) works as well as traditional laparoscopic surgery (using multiple small incisions) and may cause less pain or faster recovery.
Wenzhou, ZhejiangAges 18–80 - NCT07583927Enrolling by invitation
Blood Flow Monitoring During Stomach Cancer Surgery
This study examines how blood flow changes in tiny vessels under the tongue during a specific type of fluid management strategy in patients undergoing stomach cancer surgery. Researchers hope this information may help improve surgical outcomes and patient safety.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07583810RecruitingPhase 2
Nemtabrutinib and Rituximab for Marginal Zone Lymphoma
This trial tests a combination of two drugs—nemtabrutinib (a BTK inhibitor that targets cancer cells) and rituximab (an antibody drug)—to treat marginal zone lymphoma, a type of blood cancer. The study aims to see if this combination works better than standard treatments.
Duarte, CaliforniaAges 18 years+ - NCT07580456Recruiting
Testing AI to Read Stomach Ultrasounds Accurately
This study helps researchers train artificial intelligence (AI) to interpret ultrasound images of the stomach. You'll receive a light meal and have a quick ultrasound scan; your images help improve AI technology that doctors may use in the future.
Toronto, OntarioAges 18 years+ - NCT05349227Recruiting
After-cancer digital coaching and wearable tracking outcomes study
This study tests a digital health coaching program (using phone/tablet check-ins and wearable data) to understand health and quality-of-life outcomes after cancer treatment. It may help you learn healthy habits and track progress over time.
Gainesville, FloridaAges 18 years+ - NCT05859022Recruiting
Bariatric treatment methods compared for diabetes and metabolism
This trial compares a less invasive heart/artery-based bariatric treatment (bariatric arterial embolization) with standard weight-loss surgery to see how they affect metabolism and type 2 diabetes. You might be considered if you have obesity with type 2 diabetes and have not had prior bariatric surgery.
LisbonAges 18–75 - NCT07565051Recruiting
Predicting weight loss after gastric bypass surgery
This study looks at whether measuring muscle mass before gastric bypass surgery can predict how much weight you'll lose afterward. Understanding this connection may help doctors better prepare patients for surgery and set realistic goals.
Geneva, Canton of GenevaAges Any age - NCT07561840Recruiting
Exercise Training After Stomach or Esophagus Cancer Surgery
This study tests whether a guided exercise program helps people recover better after surgery for esophageal or gastric (stomach) cancer. Researchers will track your strength, fitness, and quality of life over time.
Hirakata, OsakaAges 18 years+ - NCT07551440Recruiting
Finding treatment targets in advanced gastric cancer
This study looks for specific genetic or molecular markers in advanced gastric cancer that has spread to other parts of the body. The goal is to identify which treatments might work best for each patient's individual cancer.
Hong KongAges 18–80 - NCT07547787Recruiting
Long-term safety follow-up for cadonilimab study participants
This is a follow-up study for people who previously received cadonilimab (AK104), an experimental cancer drug, in an earlier clinical trial. Researchers will check in with you periodically to monitor your health and collect information about how you're doing long-term.
BeijingAges Any age - NCT06743867RecruitingPhase 1
Chemotherapy mist for cancer spread in the belly
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
Guangzhou, GuangdongAges 18–75
Hear when a new Gastric or Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric or gastroesophageal junction adenocarcinoma?
- Yes. Clin2 currently lists 962 recruiting gastric or gastroesophageal junction adenocarcinoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric or gastroesophageal junction adenocarcinoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric or gastroesophageal junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.